Compare Franklin Resources, Inc. (BEN) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Franklin Resources, Inc. vs Johnson & Johnson — how do they compare? Franklin Resources, Inc. trades at $33.49 (market cap $16.95B), while Johnson & Johnson trades at $260.28 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 36.9× Franklin Resources, Inc.'s market cap, and Franklin Resources, Inc. pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BEN | JNJ | |
|---|---|---|
Market Cap | $16.95B | $626.09B |
Sector | Financials | Health |
52-Week High | $35.77 | $267.24 |
52-Week Low | $21.18 | $172.78 |
Enterprise Value | $29.90B | $654.37B |
Dividend Yield | 3.96% | 2.06% |
Volume | — | 6,156,228 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Franklin Resources (BEN) trades at $33.52, down 0.74% on the day, with a bullish technical signal supported by moving averages. The company reported Q2 2026 EPS of $0.72, beating estimates, and achieved record AUM of $1.80 trillion as of July 31, 2026, driven by strong inflows and diversification efforts. Valuation ratios include a P/E of 22.69 and P/S of 1.85, while profitability metrics show a net income margin of 8.72%.
The outlook is positive with earnings beats and AUM growth, but risks include weaker ROE of 1.34% and net cash outflows. Analyst consensus price target is $36.50, suggesting potential upside, supported by a 'Buy' rating from 22% of analysts. Investors should monitor margin expansion and competitive pressures in the asset management sector.
Johnson & Johnson (JNJ) trades at $261.81, up 0.99% on the day and near its 52-week high. The stock exhibits bullish technical signals with strong moving average support, while fundamentals show robust profitability with a net income margin of 21.48% and consistent dividend growth. Recent earnings have mostly beaten expectations, and the company maintains a solid balance sheet with $24.52 billion in cash.
The outlook for JNJ remains positive, supported by analyst consensus and a price target of $284.50. Key opportunities include its defensive healthcare positioning and pipeline strength, though risks involve patent expirations and legal headwinds. The stock offers a stable investment with growth potential in a volatile market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Franklin Resources, Inc.
Franklin Resources provides investment services for individual and institutional investors. At the end of August 2022, Franklin had $1.388 trillion in managed assets, composed primarily of equity (32%), fixed-income (38%), multi-asset/balanced (10%) funds, alternatives (16%), and money market funds (4%). Distribution tends to be weighted more toward retail investors (49% of AUM) investors, as opposed to institutional (49%) and high-net-worth (2%) clients. Franklin is also one of the more global firms of the U.S.-based asset managers with more than 35% of its AUM invested in global/international strategies and 25% of managed assets sourced from clients domiciled outside the United States.
Read more on BEN →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
